AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$HNGE

Robinson Elliott sold 0 shares of HNGE (indirect holdings)

Robinson Elliott sold 0 indirectly-held shares of Hinge Health, Inc. (HNGE) across 2 trades over 2026-06-01 to 2026-06-02.

Original reporting
SEC EDGAR · Robinson Elliott
Published Jun 3, 2026, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HNGE
Neutral
high confidence
Mentioned
$HNGE
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The filing confirms no change in insider stake; investors typically view such zero‑share transactions as non‑material.

02

Market read

Minimal relevance; the filing does not alter ownership or signal new corporate actions.

03

What to watch

Potential upcoming 10b5‑1 plan changes not disclosed.

Relevance 4/10Novelty 2/10Timing: filing date 2026-06-03

Background

SEC Form 4 filing by a director of Hinge Health, a digital health company listed on Nasdaq.

Company-level read

Ticker impact

$HNGENeutralHigh confidence
Context

Form 4 disclosed Director Robinson Elliott sold 0 shares of Hinge Health, indicating no change in holdings.

Expected impact

neutral impact as holdings remain unchanged

Evidence & confidence

Zero shares sold and no disclosed price means the transaction does not affect supply‑demand dynamics.

Market effects

Sector

None; insider activity does not signal sector trends.

Regional

None; limited to Hinge Health only.

Global

None

Counterpoint

What could challenge this read

Even a zero‑share sale could hint at future insider moves, but no actionable signal now.

Key entities

  • Director
    Robinson Elliott

    Director of Hinge Health who reported a zero‑share sale.

  • Company
    Hinge Health, Inc.

    Provider of digital musculoskeletal health solutions, ticker HNGE.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HNGE insider trading history →

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

investing.com
$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.

finance.yahoo.com